List of former news articles
Frellstedt (April 08, 2011)
Motivated by customers´ inquiries AMINO GmbH expands its product line by offering N-acetyl-L-tyrosine in addition to L-tyrosine. “Amino acid derivatives represent the logical development and completion of our product range”, Dr. Lutz Thomas, Managing Director of AMINO GmbH, states. “This strategic move means an important step on our way of optimizing the services of Amino GmbH.”
» more
|
Frellstedt (19. August 2010)
AMINO GmbH is proud to announce that L-aspartic acid, DL-aspartic acid and L-asparagine monohydrate have been added to the product line. These launches confirm AMINO’s intention to supplement its product range in order to offer an even larger variety of amino acids to its customers.
» more
|
Frellstedt (January 29, 2010)
Since its restructuring AMINO GmbH has grown its business
substantially. In order to sustain its market international presence and
to accelerate the development of the site in Frellstedt a step towards
further expanding the skill base has been taken.
» more
|
Frellstedt (February 06, 2009)
With an investment of more than € 4 mn into a second GMP production line AMINO has in 2008 laid the groundwork for sustainable growth of the business.
» more
|
Frellstedt (April 04, 2008)
AMINO GmbH adds L-phenylalanine to its product portfolio. L-phenylalanine is another essential amino acid offered by the company.
» more
|
Frellstedt (March 3, 2008) The expansion of Frellstedt plant’s production capacity for pharma-grade amino acids forms the backbone for the further enhancement for AMINO’s product offer. By adding L-proline, DL- / L-aspartic acid and L-serine in pharma-oral and pyrogen-free quality AMINO broadens its range of products.
» more
|
Frellstedt (November 23, 2007)The AMINO GmbH is expanding its production capacity at its site in Frellstedt. The reinforcement of its production technology and the specifically the duplication of the annual output capacity primarily targeted at amino acids from fermentation are the focus of the plant expansion.
» more
|
 Frellstedt (October 20, 2007) The launch of the new website of AMINO GmbH marks another milestone in the company endeavour to enforce its public appearance. Enhanced by the modern design the revised structure provides a quick and informative overview about the company and its products.
» more
|
Frellstedt (July 17, 2007) – Since its restructuring in late 2006, AMINO GmbH has taken a proactive, direct approach to generating customer contacts and thus strengthening its position in the marketplace. The response has been substantial, as evidenced by a large influx of projects to develop new products as well as new ways to make them.
» more
|
Frellstedt (May 14, 2007) – AMINO GmbH has been granted Certificates of Suitability (CEPs) by the European Directorate for the Quality of Medicines (EDQM) for the production of isoleucine and threonine via the company’s state-of-the-art fermentation process.
» more
|
Frellstedt (April 23, 2007) – Following a comprehensive audit and inpection, AMINO GmbH has been granted a production permit according to §13 paragraph 1 of the German Drug Act by the regulatory authorities of Brunswick and Oldenburg. With the implementation of the 14th amendment of the German Drug Act, manufacturers of active pharmaceutical ingredients (APIs) of microbial origin need a production permit issued by responsible authorities. AMINO GmbH produces amino acids from fermentation, which are considered APIs of microbial origin.
» more
|
Frellstedt (November 22, 2006) – A new AMINO has emerged with the completion of a leveraged management buyout of the amino acids business of AMINO GmbH. And now the company’s vision of becoming a leading supplier of specialty amino acids to the global marketplace is powered by the determination of its new management team.
» more
|